全文获取类型
收费全文 | 1478篇 |
免费 | 77篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 73篇 |
妇产科学 | 53篇 |
基础医学 | 189篇 |
口腔科学 | 22篇 |
临床医学 | 143篇 |
内科学 | 330篇 |
皮肤病学 | 70篇 |
神经病学 | 48篇 |
特种医学 | 140篇 |
外科学 | 148篇 |
综合类 | 75篇 |
一般理论 | 1篇 |
预防医学 | 71篇 |
眼科学 | 18篇 |
药学 | 113篇 |
中国医学 | 1篇 |
肿瘤学 | 43篇 |
出版年
2015年 | 8篇 |
2014年 | 13篇 |
2013年 | 34篇 |
2011年 | 9篇 |
2010年 | 25篇 |
2009年 | 40篇 |
2008年 | 17篇 |
2007年 | 14篇 |
2006年 | 18篇 |
2005年 | 14篇 |
2004年 | 8篇 |
2003年 | 14篇 |
2002年 | 13篇 |
2001年 | 9篇 |
1999年 | 12篇 |
1998年 | 31篇 |
1997年 | 64篇 |
1996年 | 48篇 |
1995年 | 43篇 |
1994年 | 42篇 |
1993年 | 40篇 |
1992年 | 34篇 |
1991年 | 16篇 |
1990年 | 27篇 |
1989年 | 38篇 |
1988年 | 32篇 |
1987年 | 25篇 |
1986年 | 34篇 |
1985年 | 37篇 |
1984年 | 18篇 |
1983年 | 15篇 |
1982年 | 17篇 |
1981年 | 19篇 |
1980年 | 19篇 |
1979年 | 11篇 |
1978年 | 16篇 |
1977年 | 26篇 |
1976年 | 13篇 |
1975年 | 10篇 |
1974年 | 9篇 |
1968年 | 10篇 |
1959年 | 38篇 |
1958年 | 69篇 |
1957年 | 82篇 |
1956年 | 67篇 |
1955年 | 92篇 |
1954年 | 83篇 |
1949年 | 42篇 |
1948年 | 44篇 |
1946年 | 8篇 |
排序方式: 共有1555条查询结果,搜索用时 15 毫秒
101.
102.
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia 总被引:1,自引:0,他引:1
Korbling M; Hunstein W; Fliedner TM; Cayeux S; Dorken B; Fehrentz D; Haas R; Ho AD; Keilholz U; Knauf W 《Blood》1989,74(6):1898-1904
Autologous bone marrow transplantation (ABMT) makes it possible to escalate the dose of cytotoxic treatment to a lethal range. Disease- free survival (DFS) following myeloablative therapy and ABMT has been shown to be superior to conventional treatment in high risk patients with acute myelogenous leukemia (AML). It was the purpose of the present study to compare hematopoietic reconstitution, actuarial DFS, and relapse rate of patients transplanted in first complete remission (CR) of AML with those in second or subsequent CR, and to evaluate transplant related mortality. Fifty-two patients with AML, 22 in first CR (low risk) and 30 in second or subsequent CR (high risk), underwent total body irradiation (12.1 to 16.7 Gy) and cyclophosphamide (CY) treatment (200 mg/kg) followed by ABMT. The autograft was incubated with the active CY derivative Mafosfamide (ASTA Werke, Bielefeld, Federal Republic of Germany) to reduce the number of possibly contaminating clonogenic tumor cells. All patients showed three lineage engraftments with platelet recovery observed as being the slowest. The transplant related death rate was low at 5.8%. There was no significant difference in the kinetics of polymorphonuclear (PMN) cell or platelet reconstitution between the low and high risk patient subgroups. The estimated probability of DFS (relapse) after ABMT in first CR was 61% (36%) compared with 34% (65%) in second or subsequent CR, the longest follow-up being 55 months and 57 months, respectively (median follow-up 31 months and 19 months, respectively). ABMT offers a stable long-term DFS when performed in first CR with no relapses occurring in over a year after transplantation. Six later relapses, however, were seen after ABMT in second or subsequent CR, although DFS was not statistically different from that of first remission patients (P = .72). 相似文献
103.
104.
Moore AD; Godwin JD; Muller NL; Naidich DP; Hammar SP; Buschman DL; Takasugi JE; de Carvalho CR 《Radiology》1989,172(1):249-254
The authors retrospectively evaluated radiographs, computed tomographic (CT) scans, and results of pulmonary function tests (when available) for 17 patients with biopsy-proved pulmonary histiocytosis X. In 11 patients, high-resolution CT was used. In 12 patients, CT demonstrated cystic air spaces, usually less than 10 mm in diameter. In three of these 12, cysts were the only abnormality, but in six others, nodules (usually less than 5 mm in diameter) were also present. Two patients had only nodules and one, only emphysema. CT showed that many lesions that appeared reticular on plain radiographs were actually cysts. CT showed no central or peripheral concentration of lesions, but it did reveal that many small nodules were distributed in the centers of secondary lobules around small airways. CT findings correlated better with the diffusing capacity (rho = -0.71) than did the plain radiographic findings (rho = -0.57). Thus, CT was better than radiography at showing the morphology and distribution of lung abnormalities. 相似文献
105.
JH Burridge DE Wood HJ Hermens GE Voerman GR Johnson F. Van Wijck T. Platz M. Gregoric R. Hitchcock AD Pandyan 《Disability and rehabilitation》2005,27(1):69-80
Purpose: To discuss the measurement of spasticity in the clinical and research environments, make recommendations based on the SPASM reviews of biomechanical, neurophysiological and clinical methods of measuring spasticity and indicate future developments of measurement tools. Method: Using the results of the systematic reviews of the biomechanical, neurophysiological and clinical approaches, methods were evaluated across three dimensions: (1) validity, reliability and sensitivity to change; (2) practical quality such as ease of use and (3) qualities specific to the measurement of spasticity, for example ability to be applied to different muscle groups. Methods were considered in terms of applicability to research and clinical applications. Results: A hierarchy of measurement approaches was identified from highly controlled and more objective (but unrelated to function) to ecologically valid, but less objective and subject to contamination from other variables. The lack of a precise definition of spasticity may account for the problem of developing a valid, reliable and sensitive method of measurement. The reviews have identified that some tests measure spasticity per se, some phenomena associated with spasticity or consequential to it and others the effect of spasticity on activity and participation and independence. Conclusions: Methods appropriate for use in research, particularly into the mechanism of spasticity did not satisfy the needs of the clinician and the need for an objective but clinically applicable tool was identified. A clinical assessment may need to generate more than one 'value' and should include evaluation of other components of the upper motor neurone syndrome. There is therefore a need for standardized protocols for 'best practice' in application of spasticity measurement tools and scales. 相似文献
106.
107.
108.
Occult fractures of the proximal femur: MR imaging 总被引:9,自引:0,他引:9
109.
True Incidence of Pacemaker Syndrome 总被引:6,自引:0,他引:6
DEBRA HELDMAN DANIEL MULVIHILL HAROLD NGUYEN JOHN C. MESSENGER ARLENE RYLAARSDAM KARLA EVANS MARK J. CASTELLANET 《Pacing and clinical electrophysiology : PACE》1990,13(12):1742-1750
HELDMAN, D., ET AL.: True Incidence of Pacemaker Syndrome. Although the purported incidence of pacemaker syndrome according to the literature is only 5%–15%, this is based on a series of patients with VVI pacing. Increasing numbers of studies are being reported in which patients prefer the dual chamber mode despite little benefit being demonstrated on objective testing, suggesting that pacemaker syndrome may be more common than is generally reported. This study was designed to evaluate the reported symptoms in a series of patients programmed to both the VVI and one or more dual chamber modes. Forty unselected patients with dual chamber pacemakers were entered into a blind, randomized trial comparing the symptoms associated with VVI pacing to those associated with dual chamber pacing. Patients were randomized to either WI or dual chamber pacing. At the end of 1 week, questionnaires rating 16 different symptoms were completed. Blood pressure, LV function, presence of ventriculoatrial conduction, and ability to override the pacemaker were evaluated. The pacemaker was then programmed to the other mode. Overall, 12 of 16 symptoms were significantly worse in the VVI as compared to dual chamber mode. The most highly significant (p < 0.005) were shortness of breath, dizziness, fatigue, pulsations in the neck or abdomen, cough, and apprehension. Pacemaker syndrome was clinically recognized in 83% of patients paced in the WI mode with 65% of patients experiencing moderate to severe symptoms. There were no readily identified clinical, hemodynamic, or electrophysiological parameters that predicted which patients would develop pacemaker syndrome. Thus, when patients have an opportunity to experience both pacing modes in close proximity to one another, there is a high incidence of pacemaker syndrome in the VVI mode. 相似文献
110.
Electroanatomical Mapping of the Heart: Basic Concepts and Implications for the Treatment of Cardiac Arrhythmias 总被引:5,自引:0,他引:5
The CARTO electroanatomical mapping system represents a paradigm shift in the ability to map the three-dimensional anatomy of the heart and determine the cardiac electrical activity at any given mapped point. The system associates anatomical structure and electrophysiological data and displays the combined information in an easily readable, visual fashion. The system consists of a roving mapping catheter with small magnetic sensors in the tip, a fixed sensor that acts as a reference point, a low magnetic field generating pad, and a data acquisition and display system. When the roving catheter is moved in three-dimensional space, its location in relation to the fixed sensor is monitored by the system, with a resolution of < 1 mm. By gating the acquisition of points in space to the cardiac electrical activity, points that represent both location and electrical activity at that location can be acquired and displayed on a computer screen. After acquiring a number of points, a three-dimensional representation is constructed, and may be displayed from any viewing projection. Clinical applications of the system include defining the mechanisms of arrhythmias, designing ablation strategies, guiding ablations, and improving the safety of mapping and ablation procedures by allowing localization of critical cardiac structures such as the atrioventricular node and His bundle. The system holds the potential to both further our understanding of arrhythmias and increase the safety, efficacy, and efficiency of catheter ablation. 相似文献